William J. Bowers, Ph.D.

Affiliations: 
Neurology, Center for Neural Development and Disease University of Rochester Medical Center, Rochester, NY, United States 
Area:
CNS Gene Therapy, Immunotherapy, Neuroinflammation, Alzheimer's Disease
Google:
"William Bowers"
Mean distance: 17.45 (cluster 11)
 
Cross-listing: Alzheimer's Tree

Children

Sign in to add trainee
Michelle C. Janelsins grad student 2002-2008 Rochester
Suresh de Silva grad student 2004-2010 Rochester
Keigan M. Park grad student 2004-2010 Rochester
Deborah A. Ryan grad student 2007-2010 Rochester
Maya K. Desai grad student 2005-2011 Rochester
Sara L. Montgomery grad student 2013 Rochester
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Southwell AL, Franciosi S, Villanueva EB, et al. (2015) Anti-semaphorin 4D immunotherapy ameliorates neuropathology and some cognitive impairment in the YAC128 mouse model of Huntington disease. Neurobiology of Disease. 76: 46-56
Evans EE, Jonason AS, Bussler H, et al. (2015) Antibody Blockade of Semaphorin 4D Promotes Immune Infiltration into Tumor and Enhances Response to Other Immunomodulatory Therapies. Cancer Immunology Research. 3: 689-701
Smith ES, Jonason A, Reilly C, et al. (2014) SEMA4D compromises blood-brain barrier, activates microglia, and inhibits remyelination in neurodegenerative disease. Neurobiology of Disease. 73: 254-268
Montgomery SL, Narrow WC, Mastrangelo MA, et al. (2013) Chronic neuron- and age-selective down-regulation of TNF receptor expression in triple-transgenic Alzheimer disease mice leads to significant modulation of amyloid- and Tau-related pathologies. The American Journal of Pathology. 182: 2285-97
Montgomery SL, Bowers WJ. (2012) Tumor necrosis factor-alpha and the roles it plays in homeostatic and degenerative processes within the central nervous system. Journal of Neuroimmune Pharmacology : the Official Journal of the Society On Neuroimmune Pharmacology. 7: 42-59
Hadaczek P, Beyer J, Kells A, et al. (2011) Evaluation of an AAV2-based rapamycin-regulated glial cell line-derived neurotrophic factor (GDNF) expression vector system. Plos One. 6: e27728
Schnell L, Hunanyan AS, Bowers WJ, et al. (2011) Combined delivery of Nogo-A antibody, neurotrophin-3 and the NMDA-NR2d subunit establishes a functional 'detour' in the hemisected spinal cord. The European Journal of Neuroscience. 34: 1256-67
Hunter JM, Bowers WJ, Maarouf CL, et al. (2011) Biochemical and morphological characterization of the AβPP/PS/tau triple transgenic mouse model and its relevance to sporadic Alzheimer's disease. Journal of Alzheimer's Disease : Jad. 27: 361-76
Montgomery SL, Mastrangelo MA, Habib D, et al. (2011) Ablation of TNF-RI/RII expression in Alzheimer's disease mice leads to an unexpected enhancement of pathology: implications for chronic pan-TNF-α suppressive therapeutic strategies in the brain. The American Journal of Pathology. 179: 2053-70
Domm W, Brooks L, Chung HL, et al. (2011) Robust antigen-specific humoral immune responses to sublingually delivered adenoviral vectors encoding HIV-1 Env: association with mucoadhesion and efficient penetration of the sublingual barrier. Vaccine. 29: 7080-9
See more...